General MedicationsINTRAVENOUS, ORALGeneric
VANCOMYCIN
VANCOMYCIN
Standard Dose
5GM/100ML (50MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview VANCOMYCIN is listed in Drugs@FDA under application 213895 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient VANCOMYCIN Form and strength SOLUTION;INTRAVENOUS, ORAL - 5GM/100ML (50MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2021-08-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview VANCOMYCIN is listed in Drugs@FDA under application 213895 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient VANCOMYCIN Form and strength SOLUTION;INTRAVENOUS, ORAL - 5GM/100ML (50MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2021-08-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.